Press Releases April 14, 2026 08:00 PM

Ridgepost Capital Schedules First Quarter 2026 Earnings Release for Thursday, May 7, 2026

Ridgepost Capital Schedules Q1 2026 Earnings Release and Conference Call for May 7, 2026

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
RPC

Ridgepost Capital, a leading provider in private markets solutions, announced it will release its Q1 2026 financial results on May 7, 2026, prior to the U.S. market open. The company will also host an earnings conference call the same day to discuss results and outlook. Ridgepost Capital manages over $43 billion in assets, focusing on Private Equity, Private Credit, and Venture Capital investments.

Ridgepost Capital Schedules First Quarter 2026 Earnings Release for Thursday, May 7, 2026
RPC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Ridgepost Capital to release Q1 2026 earnings on May 7, 2026, before market open.
  • Earnings conference call scheduled at 8:30 a.m. ET on May 7, 2026, with replay available.
  • The company manages over $43 billion in assets across private equity, private credit, and venture capital strategies targeting middle and lower-middle market investments.

DALLAS, April 15, 2026 (GLOBE NEWSWIRE) -- Ridgepost Capital, Inc. (NYSE: RPC) (“Ridgepost Capital” or the “Company”), a leading private markets solutions provider, today announced it will release its first quarter 2026 results on Thursday, May 7, 2026, before U.S. markets open.

The Company will host an earnings conference call at 8:30 a.m. Eastern Time on May 7, 2026. The webcast may be accessed here. All participants joining by telephone should register here for personal dial-in and PIN numbers.

For those unable to participate in the live call, a replay will be made available on the Company’s investor relations page.

About Ridgepost Capital
Ridgepost Capital (NYSE: RPC) is a leading private markets solutions provider with over $43 billion in assets under management as of December 31, 2025. Ridgepost Capital invests across Private Equity, Private Credit, and Venture Capital in access-constrained strategies, with a focus on the middle and lower-middle market. Ridgepost Capital’s products have a global investor base and aim to deliver compelling risk-adjusted returns. For additional information, please visit www.ridgepostcapital.com.

Ridgepost Capital Investor Contact:
[email protected]

Ridgepost Capital Media Contact:
Josh Clarkson
Taylor Donahue
[email protected]


Risks

  • Earnings results might reveal challenges or underperformance impacting investor sentiment.
  • Market conditions affecting private equity and credit markets could influence financial outcomes.
  • Uncertainties in deployment and realization of private market investments may affect future returns.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026